Respiratory syncytial virus (RSV) SH and G proteins are not essential for viral replication in vitro: Clinical evaluation and molecular characterization of a cold-passaged, attenuated RSV subgroup B mutant

Proceedings of the National Academy of Sciences of the United States of America

Volumn 94, Issue 25, 1997, Pages 13961-13966

  Karron, Ruth A ^a,b   Buonagurio, Deborah A ^c   Georgiu, Alice F ^c   Whitehead, Stephen S ^d   Adamus, Jean E ^c   Clements Mann, Mary Lou ^a,b   Harris, Denos O ^a   Randolph, Valerie B ^c   Udem, Stephen A ^c   Murphy, Brian R ^d   Sidhu, Mohinderjit S ^c  

^a JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c PFIZER INC   (United States)

^d NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

RESPIRATORY SYNCYTIAL VIRUS B1 CP 52; RESPIRATORY SYNCYTIAL VIRUS VACCINE; UNCLASSIFIED DRUG; VIRUS PROTEIN;

ADULT; ANIMAL CELL; ARTICLE; CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; GENE DELETION; HUMAN; HUMAN EXPERIMENT; INFANT; INTRANASAL DRUG ADMINISTRATION; NONHUMAN; NORMAL HUMAN; PHASE 1 CLINICAL TRIAL; PRESCHOOL CHILD; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; VACCINE PRODUCTION; VERO CELL; VIRUS GENE; VIRUS ISOLATION; VIRUS MUTANT; VIRUS REPLICATION;

ANIMALS; CERCOPITHECUS AETHIOPS; CHILD; CHROMOSOME MAPPING; GENE DELETION; GENES, VIRAL; HN PROTEIN; HUMANS; INFANT; MUTATION; RESPIRATORY SYNCYTIAL VIRUS INFECTIONS; RESPIRATORY SYNCYTIAL VIRUS, HUMAN; VACCINES, ATTENUATED; VACCINES, SYNTHETIC; VERO CELLS; VIRAL ENVELOPE PROTEINS; VIRAL PROTEINS; VIRAL VACCINES; VIRULENCE; VIRUS REPLICATION;

ANIMALIA; RESPIRATORY SYNCYTIAL VIRUS; RICE STRIPE VIRUS; RNA VIRUSES; SUBGROUP B; SYNCYTIAL VIRUS;

EID: 0031457568     PISSN: 00278424     EISSN: None     Source Type: Journal    
DOI: 10.1073/pnas.94.25.13961     Document Type: Article

References (28)

1. Collins, P. L., McIntosh, K. & Chanock, R. M. (1996) in Fields Virology, ed. Fields, B. N. (Raven, New York), pp. 1313-1351.
2. Anderson, L. J., Parker, R. A. & Strikas, R. L. (1990) J. Infect. Dis. 161, 640-646.
3. Committee on Issues and Priorities for New Vaccine Development (1985) in New Vaccine Development: Establishing Priorities (Institute of Medicine, National Academy Press, Washington, DC), p. 342.
4. Murphy, B. R., Hall, S. L., Kulkarni, A. B., Crowe, J. E., Collins, P. L., Connors, M., Karron, R. A. & Chanock, R. M. (1994) Virus Res. 32, 13-36.
5. Taylor, C. E., Morrow, S., Scott, M., Young, B. & Toms, G. L. (1989) Lancet 1, 777-778.
6. McConnochie, K. M., Hall, C. B., Walsh, E. E. & Roghmann, K. J. (1990) J. Pediatr. 117, 52-62.
7. Hall, C. B., Walsh, E. E., Schnabel, K. C., Long, C. E., McConnochie, K. M., Hildreth, S. W. & Anderson, L. J. (1990) J. Infect. Dis. 162, 1283-1290.
8. Karron, R. A., Wright, P. F., Crowe, J. E., Jr., Clements, M. L., Thompson, J., Makhene, M., Casey, R. & Murphy, B. R. (1997) J. Infect. Dis. 176, 1428-1436.
9. Crowe, J. E., Jr, Bui, P. T. & Firestone, C.-Y. (1996) J. Infect. Dis. 173, 829-839.
10. Karron, R. A., Wright, P. F., Hall, S. L., Makhene, M., Thompson, J., Burns, B. A., Tollefson, S., Steinhoff, M. C., Wilson, M. H., Harris, D. O., Clements, M. L. & Murphy, B. R. (1995) J. Infect. Dis. 171, 1107-1114.
11. Connors, M., Collins, P. L., Firestone, C.-Y., Sotnikov, A. V., Waitze, A., Davis, A. R., Hung, P. P., Chanock, R. M. & Murphy, B. R. (1992) Vaccine 10, 475-484.
12. Connors, M., Kulkarni, A. B., Firestone, C.-Y., Holmes, K. L., Morse, H. C., III, Sotnikov, A. V. & Murphy, B. R. (1992) J. Virol. 66, 7444-7451.
13. Walsh, E. E., Hall, C. B., Schlesing, J. J., Brandriss, M. W., Hildreth, S. & Paradiso, P. (1989) J. Gen. Virol. 70, 2953-2961.
14. Murphy, B. R., Sotnikov, A. V., Lawrence, L. A., Banks, S. M. & Prince, G. A. (1990) Vaccine 8, 497-502.
15. Maasab, H. F. & DeBorde, D. C. (1985) Vaccine 3, 355-369.
16. Belshe, R. B. & Hisson, F. K. (1982) J. Med. Virol. 10, 235-242.
17. Wright, P. F. & Karzon, D. T. (1987) Prog. Med. Virol. 34, 70-88.
18. Hall, S. L., Stokes, A., Tierney, E. L., London, W. T., Belshe, R. B., Newman, F. C. & Murphy, B. R. (1992) Virus Res. 22, 173-184.
19. Subbarao, E. K., Kawaoka, Y. & Murphy, B. R. (1993) J. Virol. 67, 7223-7228.
20. Stokes, A., Tierney, E. L., Sarris, C. M., Murphy, B. R. & Hall, S. L. (1993) Virus Res. 30, 43-52.
21. Firestone, C.-Y., Whitehead, S. S., Collins, P. L., Murphy, B. R. & Crowe, J. E., Jr. (1996) Virology 225, 419-422.
22. Takeuchi, K., Tanabayashi, K., Hishiyama, M. & Yamada, A. (1996) Virology 225, 156-162.
23. Markwell, M. A. K., Portner, A. & Schwartz, A. L. (1985) Proc. Natl. Acad. Sci. USA 82, 978-982.
24. Bitzer, M., Lauer, U., Baumann, C., Spiegel, M., Gregor, M. & Neubert, W. J. (1997) J. Virol. 71, 5481-5486.
25. Whitaker-Dowling, P., Lucas, W. & Youngner, J. S. (1990) Virology 175, 358-364.
26. Brown, E. G., Dimock, C. F. & Hannah, K. (1992) J. Virol. 66, 6314-6321.
27. Bukreyev, A., Camargo, E. & Collins, P. L. (1996) J. Virol. 70, 6634-6641.
28. Collins, P. L., Hill, M. G., Camargo, E., Grosfeld, H., Chanock, R. M. & Murphy, B. M. (1995) Proc. Natl. Acad. Sci. USA 92, 11563-11567.